Intervenção com Atividade Física em Idosos com Infarto do Miocárdio (PIpELINe)
Eficácia de uma intervenção de atividade física precoce e personalizada em pacientes idosos com infarto do miocárdio: o ensaio clínico randomizado PIpELINE
Elderly patients presenting with myocardial infarction (MI) are the highest risk population with the worst prognosis. No trial has ever been designed to optimize their outcome through a systematic improvement of their physical performance. Cardiac rehabilitation demonstrated to improve prognosis of patients after MI. However, real-life data shows that older patients are not referred to rehabilitation centers or they have low rate of attendance because of the high number of rehabilitation sessions and of logistic problems. So, data about effectiveness of rehabilitation programs in older MI patients is lacking.
The "Physical Activity Intervention for Elderly Patients with Reduced Physical Performance after acute coronary syndrome (HULK)" pilot study (NCT03021044) enrolled older MI patients and it demonstrated the feasibility and effectiveness of an early, tailored and low-cost physical activity intervention in terms of physical performance assessed by Short Physical Performance Battery (SPPB) score, that is strongly related to prognosis. The HULK study was focused on exercise training and not powered for hard endpoints. If a multi-domain lifestyle intervention in an adequately powered study may further improve prognosis is unknown. Thus, the investigator's hypothesis for the PIpELINe trial is that an early, tailored and low-cost multi-domain lifestyle intervention may improve prognosis of older MI patients compared to health education alone. The primary outcome is a composite of 1-year cardiovascular death and hospital readmission for cardiovascular cause.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The PIpELINe trial will include older MI patients. All patients aged 65 years and older undergoing coronary angiography because of MI must be screened for eligibility. Patient's eligibility must be assessed after percutaneous revascularization of all lesions considered susceptible of treatment. After verifying inclusion and exclusion criteria and after eligibility is confirmed, written informed consent must be obtained prior to randomization. At the time of the discharge (T0) SPPB test will be performed; in case of a score between 4 and 9, the patient will be evaluated 1-month after discharge at the inclusion visit (T1). If SPPB value is confirmed to be between 4 and 9, randomization will be performed. Key baseline patient characteristics (i.e., inclusion/exclusion criteria, demographics, medical history, details of cardiovascular anatomy and of revascularization, ECG and laboratory test results, echocardiographic data during the index hospitalization) will be recorded on the electronic Case Report Forms (eCRF). All angiographic and echocardiographic data will be collected and forwarded to a core lab for further assessment.
Randomization will be performed during the inclusion visit (T1), 30 days after discharge. Randomization will be performed centrally using an internet-based system. The patient identification number (Patient ID) and the treatment allocation will be assigned by the central randomization system. Patients will be randomized to physical activity group or health education group by a 2:1 allocation. Treatment allocation will be assigned according to a computer-generated randomization list stratified by center. All randomized patients are irrevocably in the study, whether or not they are subsequently found to be eligible, or actually receiving the allocated treatment. Therefore, all patients must be followed until the pre-specified study end date.
The aim of the study is to demonstrate that the proposed multi-domain lifestyle intervention reduces the composite endpoint of cardiovascular death and hospital readmission for cardiovascular cause. The primary endpoint is at 1 year. The follow-up will be extended up to 2 and 3 years.
The protocol includes 3 pre-specified substudies. The possibility to participate in the substudy is left to patient's decision and doesn't preclude the procedures of the main protocol.
- Anxiety and depression: previous studies reported an association between cardiovascular events and a subsequent appearance of mood disorders which could determine a lack in following secondary prevention recommendations. No data is available about these disorders in older adults. In order to assess depression after MI in older patients and the effect of physical activity intervention on mood disorders, this sub-study will be performed.
- Mitochondrial function: in both study groups the mitochondrial functional are investigated starting from blood samples and skin biopsy. Skin biopsy is performed to obtain fibroblasts. In-vitro assessment of the mitochondrial function is done on the fibroblasts of patients. The parameters obtained are related with the effectiveness of physical intervention and with the benefit obtained. A total of at least 30 patients is required.
- Lymphocyte and miRNA activity: taking into account the immunosenescence and the benefits of physical activity on the immune system, this sub-study aims to obtain data regarding T-lymphocyte function in older adults and to assess the effect of physical activity intervention on the function of the different groups of T-lymphocyte. Analyses of physical activity effects on micro ribonucleic acids (miRNAs) are also performed.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Bologna, Itália
- UO Cardiologia, Ospedale Maggiore
-
Ferrara, Itália
- Cardiology Unit
-
Lagosanto, Itália
- Cardiologia Riabilitativa, AUSL d Ferrara
-
Piacenza, Itália
- Medicina dello Sport, AUSL Piacenza
-
-
BO
-
Bologna, BO, Itália
- Medicina dello Sport SSD
-
-
FE
-
Ferrara, FE, Itália
- Centro Studi Biomedici applicati allo Sport, Ferrara
-
-
PC
-
Piacenza, PC, Itália
- Ospedale Guglielmo da Saliceto, Piacenza
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients ≥65 years
- Hospital admission for myocardial infarction
- Invasive management during index hospitalization including coronary artery angiography (± percutaneous coronary revascularization)
- SPPB value 4-9 at 1-month visit after hospital discharge
- Informed consent
Exclusion Criteria:
- Multivessel coronary artery disease or left main coronary artery disease candidate to surgical revascularization
- Planned staged percutaneous coronary intervention (PCI)
- Non-cardiovascular co-morbidity reducing life expectancy to < 1 year
- Any factor precluding 1-year follow-up
- Severe aortic or mitral disease
- Ejection fraction <30%
- Chronic heart failure New York Heart Association (NYHA) III-IV
- Severe cognitive impairment (SPMSQ <4)
- Impossibility to do physical activity due to physical impairment
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Health Education
All patients randomized to health education received a single in-person visit, one month post discharge, which included a 30-minute counselling session, supported by educational materials and tailoring of the medical treatment. The educational material provided standardized recommendations on diet, smoking cessation, and physical activity. Quality of life, functional capacity and home physical activity are assessed by proper tools. |
Current gold standard in older patients admitted to hospital for MI. The group will receive a 20-minute session with one of the study physicians. Both the patient and relatives will attend these sessions. The study physician will stress the major issues related to a heart-healthy lifestyle and will explain the importance of PA as a powerful and independent factor to improve cardiovascular health and minimize cardiovascular risk. A detailed brochure explaining the benefits of physical activity will be provided to all patients |
|
Experimental: Multi-domain lifestyle intervention
All patients randomized to experimental arm will receive diet counselling, aggressive control of CV risk factors, smoke cessation program and exercise training. The physical activity (PA) intervention will start the program with a supervised PA session immediately after the inclusion visit. Quality of life, functional capacity and daily activities will be assessed by proper tools. The program provides 6 supervised PA sessions (30, 60, 90, 180, 270 and 360 days after hospital discharge [T0]). At the end of each supervised session, calisthenics exercises derived from Otago Exercise Program are prescribed. |
The intervention includes diet counselling, smoke cessation program, aggressive CV risk control and PA intervention. The PA intervention consisted of supervised sessions combined with an individualized home-based PA program. Centre-based sessions will be supervised by a sports physician and a nurse, and will take approximately 30 to 40 minutes, including a moderate standardized treadmill-walk, and strength and balance exercises. Based on the practice sessions, patients will receive a walking program to perform at home, unsupervised. The PA programs will be individualized, and consistent with current international recommendations. A selection of calisthenic exercises will be prescribed. Participants will be encouraged to perform the exercises three times per week (approximately 20 minutes). Adjustment of the type and intensity of the home-based PA regimen will be made at each visit. The PA program will be extensively described to the patient and family members. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cumulative occurrence of cardiovascular death and hospital readmission for cardiovascular cause
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of 1-year composite endpoint of cardiovascular death plus hospital readmission for cardiovascular cause. |
1-year
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cumulative occurrence of all-cause death
Prazo: 1-year
|
To test the superiority of the early and tailored physical activity intervention over the health education alone in terms of all-cause death |
1-year
|
|
Cumulative occurrence of all-cause death
Prazo: 3-year
|
To test the superiority of the early and tailored physical activity intervention over the health education alone in terms of all-cause death |
3-year
|
|
Cumulative occurrence of cardiovascular death
Prazo: 1-year
|
To test the superiority of the early and tailored physical activity intervention over the health education alone in terms of cardiovascular death |
1-year
|
|
Cumulative occurrence of cardiovascular death
Prazo: 3-year
|
To test the superiority of the early and tailored physical activity intervention over the health education alone in terms of cardiovascular death |
3-year
|
|
Cumulative occurrence of hospital readmission for cardiovascular cause
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for cardiovascular cause. |
1-year
|
|
Cumulative occurrence of hospital readmission for cardiovascular cause
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of composite endpoint of hospital readmission for cardiovascular cause. |
3-year
|
|
Cumulative occurrence of cardiovascular death and hospital readmission for cardiovascular cause
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of composite endpoint of cardiovascular death plus hospital readmission for cardiovascular cause. |
3-year
|
|
Cumulative occurrence of hospital readmission for heart failure
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for heart failure |
1-year
|
|
Cumulative occurrence of hospital readmission for heart failure
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for heart failure |
3-year
|
|
Cumulative occurrence of hospital readmission for myocardial infarction
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for myocardial infarction |
1-year
|
|
Cumulative occurrence of hospital readmission for myocardial infarction
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for myocardial infarction |
3-year
|
|
Cumulative occurrence of hospital readmission for coronary revascularization
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for coronary revascularization |
1-year
|
|
Cumulative occurrence of hospital readmission for coronary revascularization
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for coronary revascularization |
3-year
|
|
Cumulative occurrence of cerebrovascular accident
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of cerebrovascular accident |
1-year
|
|
Cumulative occurrence of cerebrovascular accident
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of cerebrovascular accident |
3-year
|
|
Cumulative occurrence of hospital readmission for any cause
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for any cause |
1-year
|
|
Cumulative occurrence of hospital readmission for any cause
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for any cause |
3-year
|
|
Cumulative occurrence of hospital readmission for any non-cardiovascular cause
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for any non-cardiovascular cause |
1-year
|
|
Cumulative occurrence of hospital readmission for any non-cardiovascular cause
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of hospital readmission for any non-cardiovascular cause |
3-year
|
|
Cumulative occurrence of bleeding adverse events
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of bleeding adverse events |
1-year
|
|
Cumulative occurrence of bleeding adverse events
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of bleeding adverse events |
3-year
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Short Physical Performance Battery
Prazo: 6-month
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (SPPB ranges from 0 to 12, higher values mean better physical performance) |
6-month
|
|
Short Physical Performance Battery
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (SPPB ranges from 0 to 12, higher values mean better physical performance) |
1-year
|
|
Short Physical Performance Battery
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (SPPB ranges from 0 to 12, higher values mean better physical performance) |
3-year
|
|
Handgrip strength
Prazo: 6-month
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (handgrip strength, ranges from 0 to infinity, higher values mean better physical performance) |
6-month
|
|
Handgrip strength
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (handgrip strength, ranges from 0 to infinity, higher values mean better physical performance) |
1-year
|
|
Handgrip strength
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (handgrip strength, ranges from 0 to infinity, higher values mean better physical performance) |
3-year
|
|
Gait speed
Prazo: 6-month
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (10 meters gait speed ranges from 0 to infinity, higher values mean better physical performance) |
6-month
|
|
Gait speed
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (10 meters gait speed ranges from 0 to infinity, higher values mean better physical performance) |
1-year
|
|
Gait speed
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of physical performance (10 meters gait speed ranges from 0 to infinity, higher values mean better physical performance) |
3-year
|
|
EQ5D visual analogue scale
Prazo: 6-month
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of quality of life (EQ5D VAS points) |
6-month
|
|
EQ5D visual analogue scale
Prazo: 1-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of quality of life (EQ5D VAS points) |
1-year
|
|
EQ5D visual analogue scale
Prazo: 3-year
|
To assess the superiority of the early and tailored physical activity intervention over health education alone in terms of quality of life (EQ5D VAS points) |
3-year
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Tonet E, Raisi A, Zagnoni S, Chiaranda G, Pavasini R, Vitali F, Gibiino F, Campana R, Boccadoro A, Scala A, Canovi L, Amantea V, Matese C, Berloni ML, Piva T, Zerbini V, Cardelli LS, Pasanisi G, Mazzoni G, Casella G, Grazzi G, Campo G. Multi-domain lifestyle intervention in older adults after myocardial infarction: rationale and design of the PIpELINe randomized clinical trial. Aging Clin Exp Res. 2023 May;35(5):1107-1115. doi: 10.1007/s40520-023-02389-9. Epub 2023 Mar 25.
- Dal Passo B, Tonet E, Raisi A, Zagnoni S, Chiaranda G, Pasanisi G, Pavasini R, Cimaglia P, Piva T, Casella G, Caglioni S, Zerbini V, Cocco M, Menegatti E, Mandini S, Mazzoni G, Biscaglia S, Volpato S, Grazzi G, Campo G. Effectiveness of Multidomain Cardiac Rehabilitation After Myocardial Infarction by Patient Frailty: Prespecified Subgroup Analysis of the PIpELINe Trial. Circ Popul Health Outcomes. 2026 Aug 17:e013410. doi: 10.1161/CIRCOUTCOMES.126.013410. Online ahead of print.
- Tonet E, Raisi A, Zagnoni S, Chiaranda G, Pasanisi G, Aschieri D, D'Intino PE, Pavasini R, Cimaglia P, Campana R, Vitali F, Piva T, Casella G, Caglioni S, Zerbini V, Bugani G, Cocco M, Menegatti E, De Raffele M, Mandini S, Martella D, Pesenti N, Mazzoni G, Biscaglia S, Volpato S, Grazzi G, Campo G; PIpELINe Trial Investigators. Multidomain Rehabilitation for Older Patients with Myocardial Infarction. N Engl J Med. 2025 Sep 11;393(10):973-982. doi: 10.1056/NEJMoa2502799. Epub 2025 Aug 29.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 376/2019/Sper/AOUFe
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Prazo de Compartilhamento de IPD
After publication of the main findings
Critérios de acesso de compartilhamento IPD
It will be necessary a formal request to the Executive Committee of the study. The request will be analyzed and considered for acceptance
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- CIF
- ANALYTIC_CODE
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .